Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 8-bromo-beta-phenyl-1,n(2)-ethenoguanosine 3',5'-cyclic Monophosphorothioate
2. 8-bromo-beta-phenyl-1,n(2)-ethenoguanosine 3',5'-cyclic Monophosphorothioate, (r)-isomer
3. Rp-8-br-pet-cgmp(s)
1. Rp-8-br-pet-cgmp(s)
2. Rp 8br-pet-cgmps
3. 172806-21-2
4. Lp-df003
5. Df-003
6. O874z20u79
7. Unii-o874z20u79
8. 172806-20-1
9. 8-bromo-beta-phenyl-1,n(2)-ethenoguanosine 3',5'-cyclic Monophosphorothioate
10. 2-bromo-3,4-dihydro-3-(3,5-o-((r)-mercaptophosphinylidene)-beta-d-ribofuranosyl)-6-phenyl-9h-imidazo(1,2-a)purin-9-one
11. 9h-imidazo(1,2-a)purin-9-one, 2-bromo-3,4-dihydro-3-(3,5-o-((r)-mercaptophosphinylidene)-beta-d-ribofuranosyl)-6-phenyl-
12. (rp)-8-br-pet-cgmps
13. 3-[(4ar,6r,7r,7as)-2,7-dihydroxy-2-sulfanylidene-4a,6,7,7a-tetrahydro-4h-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl]-2-bromo-6-phenyl-5h-imidazo[1,2-a]purin-9-one
14. Chembl1606347
15. Schembl18074118
16. Dtxsid00938213
17. 2-bromo-3,4-dihydro-3-(3,5-o-((r)-mercaptophosphinylidene)-.beta.-d-ribofuranosyl)-6-phenyl-9h-imidazo(1,2-a)purin-9-one
18. 2-bromo-3-(2,7-dihydroxy-2-sulfanylidenetetrahydro-2h,4h-2lambda~5~-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl)-6-phenyl-3,4-dihydro-9h-imidazo[1,2-a]purin-9-one
19. 9h-imidazo(1,2-a)purin-9-one, 2-bromo-3,4-dihydro-3-(3,5-o-((r)-mercaptophosphinylidene)-.beta.-d-ribofuranosyl)-6-phenyl-
| Molecular Weight | 540.3 g/mol |
|---|---|
| Molecular Formula | C18H15BrN5O6PS |
| XLogP3 | 1.4 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 2 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 163 |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 934 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
18
PharmaCompass offers a list of 8-Bromo-pet-cyclic gmps API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right 8-Bromo-pet-cyclic gmps manufacturer or 8-Bromo-pet-cyclic gmps supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred 8-Bromo-pet-cyclic gmps manufacturer or 8-Bromo-pet-cyclic gmps supplier.
PharmaCompass also assists you with knowing the 8-Bromo-pet-cyclic gmps API Price utilized in the formulation of products. 8-Bromo-pet-cyclic gmps API Price is not always fixed or binding as the 8-Bromo-pet-cyclic gmps Price is obtained through a variety of data sources. The 8-Bromo-pet-cyclic gmps Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 8-Bromo-pet-cyclic gmps manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 8-Bromo-pet-cyclic gmps, including repackagers and relabelers. The FDA regulates 8-Bromo-pet-cyclic gmps manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 8-Bromo-pet-cyclic gmps API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 8-Bromo-pet-cyclic gmps supplier is an individual or a company that provides 8-Bromo-pet-cyclic gmps active pharmaceutical ingredient (API) or 8-Bromo-pet-cyclic gmps finished formulations upon request. The 8-Bromo-pet-cyclic gmps suppliers may include 8-Bromo-pet-cyclic gmps API manufacturers, exporters, distributors and traders.
8-Bromo-pet-cyclic gmps Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 8-Bromo-pet-cyclic gmps GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 8-Bromo-pet-cyclic gmps GMP manufacturer or 8-Bromo-pet-cyclic gmps GMP API supplier for your needs.
A 8-Bromo-pet-cyclic gmps CoA (Certificate of Analysis) is a formal document that attests to 8-Bromo-pet-cyclic gmps's compliance with 8-Bromo-pet-cyclic gmps specifications and serves as a tool for batch-level quality control.
8-Bromo-pet-cyclic gmps CoA mostly includes findings from lab analyses of a specific batch. For each 8-Bromo-pet-cyclic gmps CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
8-Bromo-pet-cyclic gmps may be tested according to a variety of international standards, such as European Pharmacopoeia (8-Bromo-pet-cyclic gmps EP), 8-Bromo-pet-cyclic gmps JP (Japanese Pharmacopeia) and the US Pharmacopoeia (8-Bromo-pet-cyclic gmps USP).
